← Home
No Priors · March 20, 2025 · 50m
Noubar Afeyan: AI in Biotech and Drug Discovery
Flagship Pioneering founder Noubar Afeyan discusses how AI is transforming drug discovery and biotech, and why the most impactful applications are not the most obvious ones.
This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.
Canon
•
Afeyan argues that biological systems represent the most complex environments AI has ever attempted to model — far more complex than language, images, or even physical robotics.
•
Afeyan traces the biography of drug discovery: each era's tools (chemistry, genomics, now AI) determined which medicines could be discovered. AI is the latest tool in this biographical arc.
Was this useful?